Drug name - Axiron
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8784878 | ELI LILLY AND CO | Transdermal delivery rate control using amorphous pharmaceutical compositions |
Jul, 2023
(9 months from now) | |
| US8993520 | ELI LILLY AND CO | Method and composition for transdermal drug delivery |
Jun, 2026
(3 years from now) | |
| US9180194 | ELI LILLY AND CO | Method and composition for transdermal drug delivery |
Jun, 2026
(3 years from now) | |
| US8807861 | ELI LILLY AND CO | Spreading implement |
Feb, 2027
(4 years from now) | |
| US8419307 | ELI LILLY AND CO | Spreading implement |
Feb, 2027
(4 years from now) | |
| US9289586 | ELI LILLY AND CO | Spreading implement |
Feb, 2027
(4 years from now) | |
| US8435944 | ELI LILLY AND CO | Method and composition for transdermal drug delivery |
Sep, 2027
(4 years from now) | |
Drugs and Companies using TESTOSTERONE ingredient
Treatment: A method of transdermally delivering testosterone; A method of increasing the testosterone blood level of an adult male subject in need thereof; A method of transdermal administration of a physiologically active agent to a subject.; A method of increasing the testosterone blood level of a person in need thereof
Dosage: SOLUTION, METERED;TRANSDERMAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 30MG/1.5ML ACTUATION | SOLUTION, METERED;TRANSDERMAL | Discontinued |
availability in other generic markets.
Click on the highlighted region to filter.